Follow
Priya Tiwari
Priya Tiwari
Central Drug Research Institute
No verified email
Title
Cited by
Cited by
Year
Activation of Angiotensin-converting Enzyme 2 Protects Against Lipopolysaccharide-induced Glial Activation by Modulating Angiotensin-converting Enzyme 2/Angiotensin (1–7)/Mas …
P Tiwari, V Tiwari, S Gupta, S Shukla, K Hanif
Molecular Neurobiology, 1-25, 2022
92022
ACE2/ANG-(1-7)/mas receptor axis activation prevents inflammation and improves cognitive functions in streptozotocin induced rat model of Alzheimer's disease-like phenotypes
V Tiwari, J Singh, P Tiwari, S Chaturvedi, S Gupta, A Mishra, S Singh, ...
European Journal of Pharmacology, 175623, 2023
82023
Angiotensin-Converting Enzyme 2 Activation Mitigates Behavioral Deficits and Neuroinflammatory Burden in 6-OHDA Induced Experimental Models of Parkinson’s Disease
S Gupta, V Tiwari, P Tiwari, Parul, A Mishra, K Hanif, S Shukla
ACS Chemical Neuroscience, 2022
82022
Ormeloxifene, a selective estrogen receptor modulator, protects against pulmonary hypertension
AO Abdulkareem, P Tiwari, ZR Lone, H Iqbal, S Gupta, RK Jha, D Chanda, ...
European Journal of Pharmacology, 175558, 2023
32023
ACE2/ANG-(1-7)/Mas Receptor Axis Activation Prevents Inflammation, Glial Activation And Cognitive Decline In a Rat Model of STZ Induced Impairment of Learning and Memory
V Tiwari, J Singh, P Tiwari, S Chaturvedi, S Gupta, A Mishra, S Singh, ...
2021
The system can't perform the operation now. Try again later.
Articles 1–5